CPA
ACH

Capital Performance Advisors’s Accendra Health ACH Stock Holding History

Capital Performance Advisors’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1
Closed -$16 – 1882
2024
Q3 		$16 Buy
+1
New +$15 ﹤0.01% 2867

Other funds holding ACH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital Performance Advisors's ACH Position: Q4 2024 in Review

Capital Performance Advisors sold out of Accendra Health (ACH) in Q4 2024, closing a stake of 1 share — an estimated $16 sold.

Capital Performance Advisors first reported a position in ACH in Q3 2024 and held it in 1 quarter. The position peaked at $16 in Q3 2024. 198 funds tracked by Wall St. Rank hold ACH as of Q4 2024.

  • Capital Performance Advisors reported no remaining Accendra Health position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 1 Accendra Health share in Q4 2024, an estimated $16.
  • Capital Performance Advisors first reported a position in Accendra Health in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Accendra Health position peaked at $16 in Q3 2024.
  • 198 funds tracked by Wall St. Rank held Accendra Health as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.